Bonaventure Equity, LLC
Venture capitalRaleigh · Pre-Seed–Series A · 12 people tracked
Investment thesis
BVE is an early-stage healthcare-focused venture firm built by founders for founders, aiming to be a catalyst rather than just a source of capital. Its mission centers on bridging funding gaps in cannabinoid and psychedelic research, backing startups at the frontier of neuroscience and patient care that target conditions such as Alzheimer's, fibromyalgia, PTSD, depression, stroke, and addiction. The firm invests in the advancement of science, works closely with entrepreneurs, and engages with regulatory reform. BVE is currently investing out of its second fund and has 16 portfolio companies.
Source: firm website, verified Aug 7, 2026.
Team · 12 people
from the firm's website & public directoriesWhat they invest in
from 6 of 7 portfolio companiesBiotech ×5AI & Machine Learning ×3Healthtech ×3AgTech ×2Deep Tech ×2Digital Health ×1FoodTech ×1Medical Devices ×1
HQs:United States×4
Investments · 7 tracked
founders shown can be your intro pathBy year:2023 · 12021 · 23 dated
Engineered Medical develops handheld spectrometers for measuring chemical compounds in agricultural and food products, including cannabinoids, phenolics, and contaminants.
AgTechFoodTech
FloraWorks develops rare and novel cannabinoid-based therapeutic ingredients, focusing on non-intoxicating cannabinoids validated through peer-reviewed research and toxicology testing.
BiotechHealthtechWellness & Fitness
Alleh Lindquist(CEO)
LeafWorks conducts plant genomics research linking genotypes to agriculturally and commercially relevant traits, and develops DNA-based tests and services for genetic identification of botanical species.
AgTechBiotechDeep TechSebastopol, US
Kerin Law(Executive Officer, Director)Eleanor Kuntz(Executive Officer, Director)William Kehoe(Executive Officer)Kerin Bentley(Executive Officer, Director)
Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Caitlyn Krebs(Co-founder + CEO)Phyllis Whiteley(Co-founder + Board Member)Randall Ussery(Co-founder + Board Member)Phyllis E. Whiteley(Executive Officer, Director)Howard Goodwin(Director)Randall S. Ussery(Director)
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Scott Rairigh(EVP, Corporate Development)Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)Magali Haas(Chief Medical Officer)
Life sciences / neuroscience company
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Portfolio news
latest coverage across their companiesSensorium Therapeutics · finsmes.com · Aug 29, 2025
Frequently asked questions
- What stage does Bonaventure Equity, LLC invest at?
- Bonaventure Equity, LLC invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Bonaventure Equity, LLC focus on?
- Bonaventure Equity, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Bonaventure Equity, LLC located?
- Bonaventure Equity, LLC is headquartered in Raleigh, US.
Similar investors
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
PsyMed Ventures is a venture capital fund investing in frontier technologies and neuroscience aimed at advancing brain and mental health.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.